Glyburide (RP-1127)

glyburide · Remedy Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Glyburide (RP-1127), covering 2024-11-12 to 2024-11-12. Get the full timeline:

Most recent: Clinical Trial Update: Glyburide (RP-1127) for Traumatic Brain Injury (TBI) [Phase 2]